|
Study to Focus on the Impact of Treatment Among Hispanic Women |
|
|
|
Sunday, 12 November 2006 |
News(Medialink) - HIV/AIDS is the fourth leading cause of death for Hispanic women ages 35 to 44. Despite this alarming trend, little progress has been made in the exploration of how women, in  | Interview with Dr. Carmen Zorrilla, University of Puerto Rico |
particular Hispanic women, respond to HIV treatments. In fact, social factors such as stigma, child care and transportation all present barriers to Hispanic women participating in such clinical trials. To date, there have been very few studies designed specifically to evaluate the impact that gender and race has on the effectiveness of HIV medications. Did you know? - Women of color women account for 80% of all women living with HIV/AIDS, with Latinas accounting for more than 15% of those cases
- Women make up nearly one-third of all new HIV diagnoses
- The proportion of AIDS cases in women has nearly doubled from 14% in 1992 to 27% in 2003
As a result, GRACE (Gender, Race And Clinical Experience), will be conducting the largest clinical study to date comparing gender and race differences in the efficacy, safety and tolerability of an HIV medication. GRACE has been designed to provide data that will ultimately lead to an improved understanding of HIV treatment in women. To get more information, go to - www.clinicaltrials.gov (search for GRACE). |
Articles 
